Table 1.
Characteristics of all patients included in the study.
Table 2.
Staging by different systems and scores, and treatments offered.
Table 3.
Univariate analysis of baseline predictors of survival.
Table 4.
Multivariate analysis of baseline predictors of survival.
Table 5.
Patient survival according to different staging systems.
Figure 1.
Survival curves for whole cohort.
Kaplan-Meier survival curves for patients with hepatocellular carcinoma by staging system: (A) Okuda, (B) Barcelona Clinic Liver Cancer, (C) Cancer of the Liver Italian Program, (D) Japan Integrated Staging score.
Table 6.
Likelihood ratio on entry of individual staging systems as factors in Cox regression model for the whole cohort.
Figure 2.
Receiver operating characteristic (ROC) curve for whole cohort.
Discriminatory ability for death at one, two, and three years, evaluated by receiver operating characteristic (ROC) curve area, for Okuda, CLIP, BCLC and JIS scores for whole cohort.
Figure 3.
Survival curves for patients not amenable to treatment.
Probability of survival for patients not amenable to treatment according to (A) CLIP score, (B) BCLC staging system.
Figure 4.
ROC curve for patients not amenable to treatment.
Discriminatory ability for death at one, two, and three years, evaluated by receiver operating characteristic (ROC) curve area, for CLIP and BCLC staging system for patients not amenable to treatment.